In contrast, RA supplementation in males with obesity (approximately 1% of energy intake for 12 weeks) reduces insulin sensitivity compared to placebo [213], thus raising concerns about the impact of RA on metabolic health. The gene discussed is INS; the disease is obesity disorder.